LeMaitre Vascular Company Profile (NASDAQ:LMAT)

About LeMaitre Vascular

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LMAT
  • CUSIP:
Key Metrics:
  • Previous Close: $23.19
  • 50 Day Moving Average: $23.85
  • 200 Day Moving Average: $21.51
  • 52-Week Range: $18,583,000.00 - $12.30
  • Trailing P/E Ratio: 43.35
  • Foreward P/E Ratio: 36.06
  • P/E Growth: 2.71
  • Market Cap: $442.28M
  • Outstanding Shares: 18,583,000
  • Beta: 0.63
  • Net Margins: 12.19%
  • Return on Equity: 12.83%
  • Return on Assets: 11.05%
  • Current Ratio: 5.66%
  • Quick Ratio: 4.21%
Additional Links:
Companies Related to LeMaitre Vascular:

Analyst Ratings

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $21.30 (10.50% downside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
DateFirmActionRatingPrice TargetDetails
11/11/2016Canaccord GenuityReiterated RatingBuy$25.00View Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00View Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00View Rating Details
7/28/2016Barrington ResearchBoost Price TargetOutperform$18.50 -> $20.00View Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50View Rating Details
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00View Rating Details
12/4/2015Benchmark Co.Boost Price Target$15.00 -> $18.00View Rating Details
12/4/2015Stifel NicolausBoost Price TargetBuy$14.00 -> $17.00View Rating Details
(Data available from 2/19/2015 forward)


Earnings History for LeMaitre Vascular (NASDAQ:LMAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2017$0.15N/AView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11ViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11ViewListenView Earnings Details
7/28/2015Q2$0.07$0.10ViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05ViewListenView Earnings Details
7/29/2014Q214$0.05$0.08$17.50 million$18.20 millionViewListenView Earnings Details
4/29/2014Q1$0.02$0.01ViewListenView Earnings Details
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
Current Year EPS Consensus Estimate: $0.57 EPS
Next Year EPS Consensus Estimate: $0.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.09$0.10$0.10
Q2 20162$0.11$0.11$0.11
Q3 20162$0.15$0.16$0.16
Q4 20162$0.16$0.17$0.17
Q1 20172$0.14$0.14$0.14
Q2 20172$0.17$0.17$0.17
Q3 20172$0.16$0.18$0.17
Q4 20172$0.19$0.19$0.19
(Data provided by Zacks Investment Research)


Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)
Annual Dividend:$0.18
Dividend Yield:0.76%
Payout Ratio:32.73% (Based on Trailing 12 Months of Earnings)
31.58% (Based on Current Year Consensus EPS Estimate)
27.27% (Based on Next Year Consensus EPS Estimate)

Dividend History for LeMaitre Vascular (NASDAQ:LMAT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for LeMaitre Vascular (NASDAQ:LMAT)
Insider Ownership Percentage: 28.90%
Institutional Ownership Percentage: 61.80%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.60View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.68View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.00View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.10View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.20View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.70View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.00View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.52View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.53View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.88View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.60View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.00View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.00View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.00View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
News IconBrokers Release Average Price Target Of 17.05 On LeMaitre Vascular, Inc. (LMAT) - UK Market News (NASDAQ:LMAT)
www.ukmarketnews.co.uk - February 17 at 8:29 AM
News IconInvestors are Watching Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Piedmont Register (NASDAQ:LMAT)
piedmontregister.com - February 15 at 12:48 AM
globenewswire.com logoLeMaitre Vascular Will Announce Fourth Quarter 2016 Earnings Results on February 21, 2017 - GlobeNewswire (press release) (NASDAQ:LMAT)
globenewswire.com - February 8 at 7:06 PM
finance.yahoo.com logoLeMaitre Vascular Will Announce Fourth Quarter 2016 Earnings Results on February 21, 2017 (NASDAQ:LMAT)
finance.yahoo.com - February 7 at 7:37 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. Presentation Now Available for On-Demand Viewing - Yahoo Finance (NASDAQ:LMAT)
finance.yahoo.com - February 6 at 10:10 AM
finance.yahoo.com logoLeMaitre Vascular, Inc. Presentation Now Available for On-Demand Viewing (NASDAQ:LMAT)
finance.yahoo.com - February 6 at 10:10 AM
finance.yahoo.com logoLeMaitre Vascular, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2 (NASDAQ:LMAT)
finance.yahoo.com - January 31 at 7:07 PM
News IconInvestor Radar: Taking a Closer Look at LeMaitre Vascular, Inc. (NASDAQ:LMAT) - The Tribune (NASDAQ:LMAT)
lakecitytribune.com - January 26 at 8:04 PM
News IconEarnings in Full Force, Analysts Take Aim at LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Wall Street Beacon (NASDAQ:LMAT)
wsbeacon.com - January 26 at 8:04 PM
News IconWhat are Research Firms Saying About LeMaitre Vascular, Inc. (NASDAQ:LMAT)? - Aiken Advocate (NASDAQ:LMAT)
aikenadvocate.com - January 26 at 8:04 PM
News IconFirst Light Asset Management LLC Has Decreased Lemaitre Vascular INC (LMAT) Holding by $3.86 Million; Stock ... - The Randolph Guide (NASDAQ:LMAT)
randolphguide.com - January 24 at 7:00 PM
capitalcube.com logoLeMaitre Vascular, Inc. : LMAT-US: Dividend Analysis : November 21st, 2016 (record date) : By the numbers : January 20, 2017 (NASDAQ:LMAT)
www.capitalcube.com - January 20 at 7:03 PM
capitalcube.com logoLeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : January 19, 2017 (NASDAQ:LMAT)
www.capitalcube.com - January 19 at 8:08 PM
capitalcube.com logoLeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : January 18, 2017 (NASDAQ:LMAT)
www.capitalcube.com - January 18 at 6:50 PM
News IconLeMaitre Vascular, Inc. LMAT Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:LMAT)
www.bioportfolio.com - January 12 at 11:51 PM
News IconStock Vaulting to Uncharted Territory: LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Wall Street Beacon (NASDAQ:LMAT)
wsbeacon.com - January 12 at 6:50 PM
News IconStock Edging Lower Out Of The Gate: LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Wall Street Beacon (NASDAQ:LMAT)
wsbeacon.com - January 12 at 6:50 PM
News IconHow To YieldBoost LeMaitre Vascular To 13.4% Using Options (NASDAQ:LMAT)
www.stockoptionschannel.com - January 11 at 6:56 PM
News IconLeMaitre Vascular, Inc. (LMAT) Valuation According To Analysts - UK Market News (NASDAQ:LMAT)
www.ukmarketnews.co.uk - January 7 at 8:35 PM
finance.yahoo.com logoLeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 12, 2017 (NASDAQ:LMAT)
finance.yahoo.com - January 5 at 7:44 PM
capitalcube.com logoETFs with exposure to LeMaitre Vascular, Inc. : January 3, 2017 (NASDAQ:LMAT)
www.capitalcube.com - January 3 at 10:01 PM
stocksdaily.net logoQuarterly Accrued Expenses Of LeMaitre Vascular, Inc. (NASDAQ ... - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - January 1 at 11:32 PM
investornewswire.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Strong Buy Recommendations At 4 - Investor Newswire (NASDAQ:LMAT)
www.investornewswire.com - December 29 at 7:42 AM
News IconTicker Tracker: Looking at LeMaitre Vascular Inc. (LMAT) - StockTalk Daily (NASDAQ:LMAT)
stocktalkdaily.com - December 21 at 7:07 PM
News IconInvestor Corner: Checking the Numbers on LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Business Daily Leader (NASDAQ:LMAT)
businessdailyleader.com - December 17 at 11:42 PM
News IconEquity Review: Looking Closer at Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - OIB News (NASDAQ:LMAT)
oibnews.com - December 16 at 4:58 AM
News IconShares in View: LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Liberty News (NASDAQ:LMAT)
libertynewsrecord.com - December 15 at 6:15 AM
News IconWhat The Charts Are Saying About LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Marion Business Daily (NASDAQ:LMAT)
marionbusinessdaily.com - December 15 at 6:15 AM
News IconFollowing the Indicators: Reviewing Levels on Shares of LeMaitre Vascular Inc. (LMAT) - StockTalk Daily (NASDAQ:LMAT)
stocktalkdaily.com - December 12 at 6:26 PM
stocksdaily.net logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Held $27.451 In Cash And ... - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - December 12 at 6:26 PM
News IconCompany in Focus: LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Liberty News (NASDAQ:LMAT)
libertynewsrecord.com - December 12 at 6:26 PM
finance.yahoo.com logoLeMaitre Vascular to Participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 (NASDAQ:LMAT)
finance.yahoo.com - December 7 at 6:15 PM
News IconInvestor Corner: Checking the Numbers for LeMaitre Vascular, Inc. (NASDAQ:LMAT) - OIB News (NASDAQ:LMAT)
oibnews.com - December 6 at 11:04 PM
stocksdaily.net logoQuarterly Accrued Expenses Of LeMaitre Vascular, Inc. (NASDAQ:LMAT) At $10.308 Millions - Stocks Daily (NASDAQ:LMAT)
www.stocksdaily.net - December 5 at 10:37 AM
News IconFree Cash Flow Score in Focus for LeMaitre Vascular, Inc. (NASDAQ:LMAT) - The Business Journal (NASDAQ:LMAT)
belmontbusinessjournal.com - November 30 at 11:25 PM
News IconMF Rank Review for LeMaitre Vascular, Inc. (NASDAQ:LMAT) - OIB News (NASDAQ:LMAT)
oibnews.com - November 30 at 11:25 PM
benzinga.com logoLeMaitre Vascular to Participate in the Benchmark... (NASDAQ:LMAT)
www.benzinga.com - November 30 at 11:59 AM
finance.yahoo.com logoLeMaitre Vascular to Participate in the Benchmark Micro Cap Discovery Conference on Thursday, December 1, 2016 (NASDAQ:LMAT)
finance.yahoo.com - November 29 at 2:14 PM
News IconCompany Focus: Zooming in on Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - The Business Journal (NASDAQ:LMAT)
belmontbusinessjournal.com - November 24 at 6:00 PM
News IconInsider Trade: LeMaitre Vascular Inc (NASDAQ:LMAT)'s President ... - Thorold News (NASDAQ:LMAT)
www.whatsonthorold.com - November 22 at 10:00 AM
News IconLeMaitre Vascular, Inc. LMAT Financial and Strategic SWOT Analysis Review Prices from USD $125 (NASDAQ:LMAT)
www.bioportfolio.com - November 17 at 5:37 PM
4-traders.com logoLEMAITRE VASCULAR INC : ex-dividend day (NASDAQ:LMAT)
www.4-traders.com - November 17 at 5:37 PM
nasdaq.com logoLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 17, 2016 - Nasdaq (NASDAQ:LMAT)
www.nasdaq.com - November 17 at 9:36 AM
investornewswire.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) :EPS Target At $0.19 - Investor Newswire (NASDAQ:LMAT)
www.investornewswire.com - November 16 at 9:37 AM
finance.yahoo.com logoLEMAITRE VASCULAR INC Financials (NASDAQ:LMAT)
finance.yahoo.com - November 15 at 6:33 PM
News IconLeMaitre (LMAT) Hits a 52-Week High on Strategic Buyout - Yahoo Sports (NASDAQ:LMAT)
sports.yahoo.com - November 15 at 9:38 AM
News IconWill LeMaitre Vascular Inc (LMAT) Continue To Underperform Its Industry? - Simply Wall St (NASDAQ:LMAT)
simplywall.st - November 15 at 9:38 AM
finance.yahoo.com logoLeMaitre (LMAT) Hits a 52-Week High on Strategic Buyout (NASDAQ:LMAT)
finance.yahoo.com - November 14 at 10:00 AM
biz.yahoo.com logoLEMAITRE VASCULAR INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:LMAT)
biz.yahoo.com - November 14 at 10:00 AM
globenewswire.com logoLeMaitre Vascular Acquires Restore Flow Allografts - GlobeNewswire (press release) (NASDAQ:LMAT)
globenewswire.com - November 12 at 6:04 PM


What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular declared a quarterly dividend on Thursday, October 27th. Shareholders of record on Monday, November 21st will be given a dividend of $0.045 per share on Monday, December 5th. This represents a $0.18 annualized dividend and a yield of 0.76%. The ex-dividend date is Thursday, November 17th.

Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2017?

5 equities research analysts have issued 12-month price objectives for LeMaitre Vascular's shares. Their predictions range from $18.50 to $25.00. On average, they anticipate LeMaitre Vascular's stock price to reach $21.30 in the next year.

When will LeMaitre Vascular announce their earnings?

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.

Who owns LeMaitre Vascular stock?

LeMaitre Vascular's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (4.89%), Columbia Wanger Asset Management LLC (4.87%), State Street Corp (1.78%), Allianz Asset Management AG (1.60%), William Blair Investment Management LLC (1.51%) and Axiom International Investors LLC DE (1.12%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Joseph P Pellegrino, Jr, Lawrence J Jasinski, Peter R Gebauer and Trent G Kamke.

Who sold LeMaitre Vascular stock? Who is selling LeMaitre Vascular stock?

LeMaitre Vascular's stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, GSA Capital Partners LLP, Renaissance Technologies LLC, First Light Asset Management LLC, Allianz Asset Management AG, Bowling Portfolio Management LLC, Menta Capital LLC and Systematic Financial Management LP. Company insiders that have sold LeMaitre Vascular stock in the last year include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Lawrence J Jasinski, Peter R Gebauer and Trent G Kamke.

Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?

LeMaitre Vascular's stock was purchased by a variety of institutional investors in the last quarter, including Columbia Wanger Asset Management LLC, Axiom International Investors LLC DE, Dimensional Fund Advisors LP, Federated Investors Inc. PA, Russell Investments Group Ltd., AQR Capital Management LLC, State Street Corp and Bogle Investment Management L P DE.

How do I buy LeMaitre Vascular stock?

Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of LeMaitre Vascular stock cost?

One share of LeMaitre Vascular stock can currently be purchased for approximately $23.80.

LeMaitre Vascular (NASDAQ:LMAT) Chart for Sunday, February, 19, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Earnings History Chart

Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Dividend History Chart

Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Last Updated on 2/19/2017 by MarketBeat.com Staff